West african pharmaceutical sovereignty takes shape in Lomé

Lomé, August 13, 2026 — West Africa stands at a critical juncture between importing medicines at scale or building its own health industry. This stark reality brought together regional medical and academic leaders on August 12 at Lomé’s Agora Senghor, where a comprehensive overhaul of West African health strategy was set in motion.

Organized by the Federation of West African Pharmacy Students (FESPAO) for its 21st Scientific and Cultural Conference, the gathering of emerging medical professionals went beyond budgetary appeals. They demanded a fundamental shift in approach—moving from a distribution-driven model to one centered on industrialization, genomic research, and scientific validation of traditional knowledge.

Local production: a national security imperative

The global pandemic and recent supply chain disruptions have exposed a harsh truth: reliance on pharmaceutical imports is no longer just an economic anomaly—it has become a critical national security flaw. This was the core argument advanced during the summit.

Professor Gado Tchangbédji, Togo’s Deputy Minister for Higher Education and Research, outlined the government’s new direction under President Faure Essozimna Gnassingbé: positioning Togo as a leader in pharmaceutical innovation and local production to shield the region from future health crises. The state has pledged substantial support to strengthen scientific cooperation and applied research initiatives.

The genomic epidemiology and indigenous knowledge gamble

Yet local production alone is insufficient if it merely replicates foreign patents. True sovereignty demands treatments tailored to Africa’s unique health landscape. By prioritizing genomic epidemiology, the Lomé conference underscored a pressing need: developing therapies aligned with the genetic makeup of African populations—currently underrepresented in global clinical trials.

This scientific ambition is complemented by a cultural reawakening. Experts advocate for industrializing traditional pharmacopeia, moving beyond informal herbal remedies to rigorously test and patent entirely African-derived active compounds.

Redefining the pharmacist’s role

This industrial and scientific vision faces a human capital challenge. As the sector evolves, so must academic training. Professor Tchin Darré, Deputy Minister of Health and Dean of the Faculty of Health Sciences at the University of Lomé, identified the linchpin of this revolution: curriculum reform. Tomorrow’s West African pharmacist must transcend the role of a simple dispenser behind a counter. They need to emerge as cutting-edge researchers, key players in manufacturing, and specialists in validating indigenous knowledge.

With discussions ongoing in Lomé, the 21st edition of these Assizes has a clear mission: translate academic debates into enforceable public policies so that universal healthcare access in West Africa no longer hinges on factories thousands of miles away from patients.

The stakes could not be higher. Without a robust local pharmaceutical industry and research grounded in African realities, West Africa will remain dependent on external solutions. In the face of future pandemics, this dependence could cost lives. True health sovereignty will be determined by each nation’s ability to turn these resolutions into tangible action—ensuring every African patient receives care designed, validated, and produced on the continent.